Montelukast as a Rescue and Premedication for Rituximab Infusion Reactions.
J Rheumatol
; 2024 Jun 15.
Article
em En
| MEDLINE
| ID: mdl-38879194
ABSTRACT
Rituximab (RTX) is a monoclonal antibody often used in patient treatment of malignancies and several rheumatological disorders, including vasculitides.1-3 It has become an essential component of many treatment protocols; however, is commonly associated with hypersensitivity infusion reactions.1.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Rheumatol
Ano de publicação:
2024
Tipo de documento:
Article